Field-deployable viral diagnostics using CRISPR-Cas13
Posted by btwatson on April 27, 2018 12:03 am
Tags:
Categories:
Crispr Articles
Source: Field-deployable viral diagnostics using CRISPR-Cas13
Cameron Myhrvold
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Catherine A. Freije
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
Jonathan S. Gootenberg
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.McGovern Institute for Brain Research, MIT, Cambridge, MA 02139, USA.Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA.Department of Biological Engineering, MIT, Cambridge, MA 02139, USA.
Omar O. Abudayyeh
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.McGovern Institute for Brain Research, MIT, Cambridge, MA 02139, USA.Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA.Department of Biological Engineering, MIT, Cambridge, MA 02139, USA.Department of Health Sciences and Technology, MIT, Cambridge, MA 02139, USA.
Hayden C. Metsky
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, USA.
Ann F. Durbin
Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.Institute for Medical Engineering and Science, MIT, Cambridge, MA 02139, USA.
Max J. Kellner
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Amanda L. Tan
Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Lauren M. Paul
Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Leda A. Parham
Centro de Investigaciones Genética, Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Kimberly F. Garcia
Centro de Investigaciones Genética, Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Kayla G. Barnes
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, MA 02115, USA.
Bridget Chak
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Adriano Mondini
Araraquara Laboratory of Public Health, School of Pharmaceutical Sciences, São Paulo State University, São Paulo, Brazil.
Mauricio L. Nogueira
Laboratorio de Pesquisas em Virologia, Faculdade de Medicina de Sao Jose do Rio Preto, São Paulo, Brazil.
Sharon Isern
Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Scott F. Michael
Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Ivette Lorenzana
Centro de Investigaciones Genética, Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Nathan L. Yozwiak
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Bronwyn L. MacInnis
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, MA 02115, USA.
Irene Bosch
Institute for Medical Engineering and Science, MIT, Cambridge, MA 02139, USA.Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
Lee Gehrke
Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.Institute for Medical Engineering and Science, MIT, Cambridge, MA 02139, USA.Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.
Feng Zhang
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.McGovern Institute for Brain Research, MIT, Cambridge, MA 02139, USA.Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA.Department of Biological Engineering, MIT, Cambridge, MA 02139, USA.
Pardis C. Sabeti
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, MA 02115, USA.Howard Hughes Medical Institute (HHMI), Chevy Chase, MD 20815, USA.
Published at Thu, 26 Apr 2018 17:50:39 +0000
Crispr News
-
Crispr: My Long Term 'Wait And Watch' Punt On The Future Of Gene Editing (NASDAQ:CRSP) - Seeking AlphaAugust 8, 2022
-
New portable diagnostic detects SARS-CoV-2 RNA and antibodies at the same time - EurekAlertAugust 8, 2022
-
CRISPR Therapeutics GAAP EPS of -$2.40 misses by $0.19, revenue of $0.16M misses by $2.04M (NASDAQ:CRSP) - Seeking AlphaAugust 8, 2022
-
CRISPR THERAPEUTICS AG Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.comAugust 8, 2022
-
Pfizer bets $5.4bn against gene therapies in sickle cell - Evaluate PharmaAugust 8, 2022
-
Epigenic Therapeutics raises $20M for gene editing technology - Labiotech.euAugust 8, 2022
-
Episode 11 - CRISPR with Dr Jakob Haaber & Dr Richard Fox - Drug Target ReviewAugust 8, 2022
-
CRISPR and Cas Genes Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2029 – Shanghaiist - ShanghaiistAugust 8, 2022
-
Vertex: Q2 2022 Earnings Steady - But Expect Volatility Soon (NASDAQ:VRTX) - Seeking AlphaAugust 5, 2022
-
New Products Posted to GenomeWeb: Thermo Fisher, Seer, Novacyt, Artisan Bio, More - GenomeWebAugust 5, 2022
-
'TnpB protein, a new tool in CRISPR-Cas gene editing' - KBRAugust 5, 2022
-
Cancers and heart disease could be diagnosed more easily with new rapid test - Imperial College LondonAugust 4, 2022
-
Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress - Yahoo FinanceAugust 4, 2022
-
Global Genome Editing Technologies market is projected to grow at a CAGR of 15.96% by 2032: Visiongain Re - BenzingaAugust 4, 2022
-
Podcast: CRISPR can cause cancer? Vitamin B6 may fight depression; COVID 'groupthink' - Genetic Literacy ProjectAugust 4, 2022
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.